Preclinical evaluation of XPO1 inhibition in Wilms tumors.

被引：0
|
作者：
Ortiz, Michael Vincent
Siddiquee, Armaan
You, Daoqi
Mundi, Prabhjot Singh
Marks, Lianna Q.
Guillan, Kristina
Diolaiti, Daniel
Aburi, Mahalaxmi
Califano, Andrea
Dela Cruz, Filemon S.
Kung, Andrew
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Columbia Univ, Med Ctr, New York, NY USA
[3] Stanford Univ, Palo Alto, CA 94304 USA
[4] Columbia Univ, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3580
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Therapeutic Effects of XPO1 Inhibition in Thymic Epithelial Tumors
    Conforti, Fabio
    Zhang, Xu
    Rao, Guanhua
    De Pas, Tommaso
    Yonemori, Yoko
    Antonio Rodriguez, Jose
    McCutcheon, Justine N.
    Rahhal, Raneen
    Alberobello, Anna T.
    Wang, Yisong
    Zhang, Yu-Wen
    Guha, Udayan
    Giaccone, Giuseppe
    CANCER RESEARCH, 2017, 77 (20) : 5614 - 5627
  • [2] AKTing on XPO1 inhibition in AML
    Stefanie Göllner
    Carsten Müller-Tidow
    Nature Cancer, 2022, 3 : 787 - 789
  • [3] The synergistic effect of melphalan and XPO1 inhibition in preclinical models of multiple myeloma
    Turner, J.
    Bauer, A.
    Dawson, J.
    Gomez, J.
    Nishihori, T.
    Sullivan, D.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E116 - E116
  • [4] XPO1 Inhibition Enhances Radiation Response in Preclinical Models of Rectal Cancer
    Ferreiro-Neira, Isabel
    Torres, Nancy E.
    Liesenfeld, Lukas F.
    Chan, Carlos H. F.
    Penson, Tristan
    Landesman, Yosef
    Senapedis, William
    Shacham, Sharon
    Hong, Theodore S.
    Cusack, James C.
    CLINICAL CANCER RESEARCH, 2016, 22 (07) : 1663 - 1673
  • [5] The synergistic effect of melphalan and XPO1 inhibition in preclinical models of multiple myeloma
    Turner, Joel G.
    CANCER RESEARCH, 2017, 77
  • [6] Radiation response enhanced by inhibition of XPO1 in preclinical rectal cancer models
    von Fallois, Moritz
    Depping, Reinhard
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 (12) : 961 - 962
  • [7] Strahlensensibilität durch Inhibition von XPO1 in Zelllinien kolorektaler Karzinome gesteigertRadiation response enhanced by inhibition of XPO1 in preclinical rectal cancer models
    Moritz von Fallois
    Reinhard Depping
    Strahlentherapie und Onkologie, 2016, 192 : 961 - 962
  • [8] AKTing on XPO1 inhibition in AML
    Goellner, Stefanie
    Mueller-Tidow, Carsten
    NATURE CANCER, 2022, 3 (07) : 787 - 789
  • [9] Xpo1 Inhibition: A Promising Therapeutic Strategy in Thymic Epithelial Tumors
    Conforti, Fabio
    De Pas, Tommaso
    Alberobello, AnnaT.
    Rao, Guanhua
    Wang, Yisong
    Giaccone, Giuseppe
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S254 - S254
  • [10] Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma
    Nakayama, Robert
    Zhang, Yi-Xiang
    Czaplinski, Jeffrey T.
    Anatone, Alex J.
    Sicinska, Ewa T.
    Fletcher, Jonathan A.
    Demetri, George D.
    Wagner, Andrew J.
    ONCOTARGET, 2016, 7 (13) : 16581 - 16592
12345